No
from Section III - Ovarian Cancer
Published online by Cambridge University Press: 20 July 2023
The choice of therapy for first relapse of low-grade serous carcinoma – the focus of this debate – is based on several key factors, including type of primary therapy, efficacy and side effects of standard regimens, availability of clinical trials, and patient preferences. Three clinical trials have provided evidence that MEK inhibitors possess promising activity against recurrent disease. However, they are associated with potentially significant side effects. There are several options for treatment of relapse, including chemotherapy, endocrine therapies, bevacizumab, and targeted agents. However, there is no standard for sequencing of these drugs. My preference is for a clinical trial at first relapse. Off protocol, for women who have not previously received an aromatase inhibitor, this is my recommendation for first relapse. For those who have previously received an aromatase inhibitor, based on the findings in the MILO trial and the therapeutic index of MEK inhibitors, pegylated liposomal doxorubicin is my preference at first relapse.
To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Find out more about the Kindle Personal Document Service.
To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.
To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.